Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William T Carpenter, MD
Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicien
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ezrath Nashim Association, Sarah Herzog Memorial Hospital
Jerusalem, Israel
- Ucla/va Greater Los Angeles Health Care System
Los Angeles, California, United States
- Maryland Psychiatric Research Center
Baltimore, Maryland, United States
- Zucker Hillside Hospital
Glen Oaks, New York, United States
- Nathan S Kline Institute for Psychiatric Research
Orangeburg, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2000
- Primary completion
- 30 Jun 2004
- Completion
- 30 Jun 2004
- Last update posted
- 20 Aug 2019
- Registered enrollment
- 240
- Registry id
- NCT00222235
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.